Results 21 to 30 of about 33,694 (186)

Familial Cluster of Foodborne Botulism Associated with Homemade Dairy Products: A Case Series [PDF]

open access: yesInternational Medical Case Reports Journal
Khadijeh Saravani,1 Amirhosein Kamrava,2 Javad Poursamimi3 1Department of Forensic Medicine and Toxicology, Zabol University of Medical Science, Zabol, Iran; 2Student Research Committee, Zabol University of Medical Sciences, Zabol, Iran; 3Department of ...
Saravani K, Kamrava A, Poursamimi J
doaj   +2 more sources

Infant botulism in Australia: availability of human botulinum antitoxin for treatment

open access: yesMedical Journal of Australia, 2010
We report the first Australian case of treatment of infant botulism with a human botulinum antitoxin developed in the United States by the California Department of Public Health. Our patient's clinical improvement was rapid, and although the product is expensive, cost-analysis supports the economical viability of its use.
May, M. L. A.   +2 more
openaire   +5 more sources

Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures [PDF]

open access: yesSaudi Pharmaceutical Journal
Botulism is a severe neuroparalytic syndrome caused by botulinum neurotoxins (BoNTs)—among the most potent biological agents—with an estimated human lethal dose (LD50) of approximately 1 ng/kg.
Sultan Almudimeegh
doaj   +2 more sources

Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

open access: yesDisease Models & Mechanisms, 2018
Botulinum neurotoxin (BoNT) serotypes A, B and E are responsible for most cases of human botulism. The only approved therapy for botulism is antitoxin treatment administered to patients after symptom onset.
Amram Torgeman   +11 more
doaj   +2 more sources

Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana

open access: yesHuman Vaccines & Immunotherapeutics
Botulism is a fatal neurologic disease caused by the botulinum toxin (BoNT) produced by Clostridium botulinum. It is a rare but highly toxic disease with symptoms, such as cramps, nausea, vomiting, diarrhea, dysphagia, respiratory failure, muscle ...
Kornchanok Sangprasat   +6 more
doaj   +2 more sources

Chronic Botulism in Humans: A Case Series. [PDF]

open access: yesClin Case Rep
ABSTRACT This study presents novel clinical presentations of botulism, observed in both patients and goats from the same farm. Their symptoms appeared at the same time, suggesting a possible relation to animal visceral botulism. Interestingly, weight loss and weakness were the persistent signs, but not life‐threatening as expected in botulism.
Barzegar MS, Pourhemmati S, Mardani M.
europepmc   +2 more sources

Diagnosis and treatment of botulism after botulinum toxin type A injections: report of 9 cases

open access: yesDi-san junyi daxue xuebao, 2021
Objective To explore the diagnostic criteria of botulism after botulinum toxin type A (BT/A) injection and observe the therapeutic effect of botulinum antitoxin.
HE Ping   +5 more
doaj   +1 more source

Infant Botulism: A Case Study in Integrated Clinical and Public Health Response. [PDF]

open access: yesClin Case Rep
ABSTRACT Early recognition of constipation, feeding difficulty, and descending weakness in infants is vital for prompt diagnosis of infant botulism. Bedside nerve studies support early treatment. Rapid public health notification and coordinated access to specific therapies, including timely use of BAT and BIG‐IV, are essential to optimize outcomes and ...
Gannon J   +10 more
europepmc   +2 more sources

Clostridium botulinum – like organism bacteremia in a user of black tar heroin

open access: yesIDCases, 2021
Wound botulism due to introduction of the anaerobic bacteria, Clostridium botulinum, into otherwise sterile, relatively anaerobic tissue is a known complication of black tar heroin use.
Therese Battiola   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy